Invention Grant
- Patent Title: Antibodies to FeRn and uses thereof
- Patent Title (中): FeRn抗体及其用途
-
Application No.: US14168839Application Date: 2014-01-30
-
Publication No.: US09260520B2Publication Date: 2016-02-16
- Inventor: Christopher TenHoor , Arumugam Muruganandam , Robert Charles Ladner , Clive Wood , Alan J. Bitonti , James McGivney , Kevin McDonnell , Liming Liu , Jennifer Dumont , Aaron K. Sato , Malini Viswanathan
- Applicant: DYAX CORP. , BIOGEN HEMOPHILIA INC.
- Applicant Address: US MA Burlington US MA Cambridge
- Assignee: DYAX CORP.,BIOGEN HEMOPHILIA INC.
- Current Assignee: DYAX CORP.,BIOGEN HEMOPHILIA INC.
- Current Assignee Address: US MA Burlington US MA Cambridge
- Agency: Drinker Biddle & Reath LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; G01N33/579 ; G01N33/68 ; A61K39/00
Abstract:
This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
Public/Granted literature
- US20140248287A1 FC RECEPTOR BINDING PROTEINS Public/Granted day:2014-09-04
Information query
